Related Experiment Video
Updated: Aug 12, 2026

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
Published on: July 25, 2011
DNA damage and repair in the brain after cerebral ischemia
1Department of Neurosurgery, Baylor College of Medicine, Houston, TX 77030, USA. philipl@bcm.tmc.edu
Abstract:
In experimental models of brain injury of the ischemia-reperfusion type, there is a period of time in which the formation of oxidative damage exceeds its repair. Simultaneously, the expression of immediate early genes is induced to activate the expression of late effector genes. Drugs that reduce the need to repair during this transient period of time also attenuate neuronal death after brain injury. An example discussed in this review is the activator protein-1 (AP-1), the product of the c-fos gene and other immediate early genes. What is the effect of a delayed expression of these genes in relationship to the process of cell death? This short period presents a window of opportunity to study the effects of oxidative damage on gene expression in the brain and specific deficiencies in gene repair that have been associated with particular neurological disorders.
Insights
Targeted interventions during a critical window after brain injury can reduce neuronal death. Understanding oxidative damage and gene expression, like activator protein-1 (AP-1), is key to developing new treatments for neurological disorders.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- Ischemia-reperfusion brain injury involves a period where oxidative damage outpaces repair.
- This injury triggers the expression of immediate early genes, which in turn activate late effector genes.
Purpose of the Study:
- To investigate the role of immediate early gene expression in neuronal death following brain injury.
- To explore the therapeutic potential of modulating gene repair during the critical post-injury window.
Main Methods:
- Review of experimental models of ischemia-reperfusion brain injury.
- Analysis of the temporal relationship between oxidative damage, gene expression (e.g., activator protein-1), and neuronal cell death.
Main Results:
- Drugs that mitigate the need for repair during the acute phase of injury can reduce neuronal death.
- The expression of immediate early genes, such as activator protein-1 (AP-1), is a critical factor in the cell death pathway.
Conclusions:
- A transient window exists post-brain injury where oxidative damage impacts gene expression.
- Targeting gene repair mechanisms during this window offers a therapeutic strategy for neurological disorders.
- Delayed gene expression may influence the progression of cell death after brain injury.
Related Concept Videos
Neurogenesis and Regeneration of Nervous Tissue
Ischemic Stroke ll: Pathophysiology

